USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/13304
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVarghese, Nevin-
dc.date.accessioned2020-11-26T10:56:49Z-
dc.date.available2020-11-26T10:56:49Z-
dc.date.issued2020-10-
dc.identifier.urihttps://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/13304-
dc.descriptionDepartement of Internal Medicine-semiology, State University of Medicine and Pharmacy "Nicolae Testemitanu", Chișinău, Republic of Moldova, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltareen_US
dc.description.abstractIntroduction: Systemic lupus erythematosus (SLE), a chronic autoimmune disease, is characterized by multi-systemic impairment and, respectively, leads to decreased quality of life (QoL) in patients. Arterial Hypertension (AHT) is a common commorbidity in patients with SLE, with the potential to affect QoL. Respectively, studying the QoL in the case of the association of SLE with AHT is a challenge. Purpose: To study Quality of Life in patients with Systemic lupus erythematosus and arterial hypertension. Material and methods: Case-control study, that included 2 groups of patients: SLE without AHT - group 1, SLE with AHT - group 2. QoL was quantified by SF-8 questionnaire, total SF-8 (SF-8t) were calculated, Mental SF-8 (SF-8m) and physical SF-8 (SF-8f). Results: The study included 23 patients with SLE (SLICC criteria, 2012). The F: M ratio was 14: 1, the mean age was 41.2 ± 12.7 years. The duration of the disease was 80.1 ± 42.5 months, SLEDAI activity of 8.0 ± 7.8 points. • Group 1 - 11 patients with SLE without AHT, • Group 2 -12 patients with SLE and AHT. Conclusions: Patients with SLE was observed to have decreased QoL indices from the physical and mental components. Arterial Hypertension, is a comorbidity frequently associated with patients with SLE, which negatively influences the physical component of QoL, which implies the need for targeted management of BP values in these patients.en_US
dc.language.isoenen_US
dc.publisherUniversitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu"en_US
dc.subjectsystemic lupus erythematosusen_US
dc.subjectarterial hypertensionen_US
dc.subjectquality of lifeen_US
dc.titleQuality of life in patients with systemic lupus erythematosis and arterial hypertensionen_US
dc.typeOtheren_US
Appears in Collections:Culegere de postere

Files in This Item:
File Description SizeFormat 
Varghese_QUALITY_OF_LIFE_IN_PATIENTS_WITH_SYSTEMIC_LUPUS_ERYTHEMATOSIS_AND_ARTERIAL_p.175.pdf206.09 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback